{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:58:43Z","timestamp":1776391123359,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pfizer Global Pharmaceuticals"},{"name":"Research to Prevent Blindness, Inc"},{"DOI":"10.13039\/100014476","name":"Pfizer Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Allergan Pharmaceuticals"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi Aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ajo.2010.01.037","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T04:34:26Z","timestamp":1274416466000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Increased Cost of Medical Services for People Diagnosed With Primary Open-Angle Glaucoma: A Decision Analytic Approach"],"prefix":"10.1016","volume":"150","author":[{"given":"Steven M.","family":"Kymes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Plotzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Fain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2010.01.037_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib2","series-title":"Vision Problems in the United States","author":"Friedman","year":"2002"},{"key":"10.1016\/j.ajo.2010.01.037_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199111143252004","article-title":"Racial differences in the cause-specific prevalence of blindness in east Baltimore","volume":"325","author":"Sommer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2010.01.037_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/archopht.122.3.376","article-title":"The Ocular Hypertension Treatment Study: intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease?","volume":"122","author":"Robin","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ip.6.3.177","article-title":"Cost of illness studies: what is good about them?","volume":"6","author":"Rice","year":"2000","journal-title":"Inj Prev"},{"key":"10.1016\/j.ajo.2010.01.037_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ophtha.2006.07.054","article-title":"Association between vision loss and higher medical care costs in Medicare beneficiaries' costs are greater for those with progressive vision loss","volume":"114","author":"Javitt","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2010.01.037_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archopht.125.4.544","article-title":"Economic impact of visual impairment and blindness in the United States","volume":"125","author":"Frick","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","article-title":"The economic burden of major adult visual disorders in the United States","volume":"124","author":"Rein","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ophtha.2006.10.031","article-title":"Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data","volume":"114","author":"Lee","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2010.01.037_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ijg.0000212250.95078.6f","article-title":"Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study","volume":"15","author":"Gieser","year":"2006","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2010.01.037_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00061198-200312000-00002","article-title":"Cost of glaucoma in Canada: analyses based on visual field and physician's assessment","volume":"12","author":"Iskedjian","year":"2003","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2010.01.037_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.124.1.12","article-title":"A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma","volume":"124","author":"Lee","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/112067210801800109","article-title":"The costs of treating glaucoma with combinations of topical drugs in Spain","volume":"18","author":"Neymark","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib14","series-title":"Employer Health Benefits: 2007 Annual Survey","year":"2008"},{"key":"10.1016\/j.ajo.2010.01.037_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jclinepi.2005.07.010","article-title":"Different factor loadings for SF36: the Strong Heart Study and the National Survey of Functional Health Status","volume":"59","author":"Beals","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajo.2010.01.037_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1076\/opep.10.1.3.13773","article-title":"Visual impairment and nursing home placement in older Australians: the Blue Mountains Eye Study","volume":"10","author":"Wang","year":"2003","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ajo.2010.01.037_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajo.2010.01.037_bib18","author":"Hunt"},{"key":"10.1016\/j.ajo.2010.01.037_bib19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00019053-200624110-00002","article-title":"Recent developments in decision-analytic modeling for economic evaluation","volume":"24","author":"Weinstein","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ajo.2010.01.037_bib20","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0161-6420(01)00754-0","article-title":"Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration","volume":"108","author":"Brody","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2010.01.037_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2007.04.048","article-title":"Depression and mood indicators in newly diagnosed glaucoma patients","volume":"144","author":"Jampel","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jamda.2005.04.001","article-title":"Unmet visual needs of Alzheimer's disease patients in long-term care facilities","volume":"6","author":"Koch","year":"2005","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ajo.2010.01.037_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1442-9071.2000.00236.x","article-title":"Visual function tests, eye disease and symptoms of visual disability: a population-based assessment","volume":"28","author":"Ivers","year":"2000","journal-title":"Clin Exper Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ophtha.2003.09.033","article-title":"Higher risk of multiple falls among elderly women who lose visual acuity","volume":"111","author":"Coleman","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2010.01.037_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0272989X8300300403","article-title":"The Markov process in medical prognosis","volume":"3","author":"Beck","year":"1983","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajo.2010.01.037_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/archophthalmol.2008.571","article-title":"The association of primary open-angle glaucoma with mortality: a meta-analysis of observational studies","volume":"127","author":"Akbari","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1037\/0022-006X.61.6.952","article-title":"Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence","volume":"61","author":"Willet","year":"1993","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.ajo.2010.01.037_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archopht.126.6.849","article-title":"Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma","volume":"126","author":"Bramley","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.01.037_bib29","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.ajo.2010.01.037_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/IJG.0b013e3181752c83","article-title":"Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire","volume":"18","author":"Goldberg","year":"2009","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2010.01.037_bib31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/IJG.0b013e318163bdd1","article-title":"Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15","volume":"17","author":"Skalicky","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2010.01.037_bib32","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2006.04.028","article-title":"Impact of severity and bilaterality of visual impairment on health-related quality of life","volume":"113","author":"Varma","year":"2006","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:01:09Z","timestamp":1757595669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939410000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0002939410000796"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2010.01.037","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Increased Cost of Medical Services for People Diagnosed With Primary Open-Angle Glaucoma: A Decision Analytic Approach","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2010.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}